ConductScience.org, home

Gene · 5818

NECTIN1: nectin cell adhesion molecule 1

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. NECTIN1: nectin cell adhesion molecule 1. Genes, record 5818. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5818

On this page

Gene

Symbol
NECTIN1
HGNC
Name
nectin cell adhesion molecule 1
HGNC
NCBI Gene ID
5818
NCBI Gene
HGNC ID
HGNC:9706
HGNC
Ensembl
ENSG00000110400
NCBI Gene
Aliases
CD111, CLPED1, ED4, HIgR, HV1S, HVEC, Nectin-1, OFC7, PRR, PRR1, PVRL1, PVRR, PVRR1, SK-12, nectin-1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q15223Nectin-15176Ensembl, GeneID, HGNC

Source UniProt

Patents51

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4777615 A12026-07-2224Q15223Espacenet
JP 2026004568 A2026-01-1458293Q15223Espacenet
EP 4650780 A22025-11-192286Q15223Espacenet
EP 4641201 A22025-10-291856Q15223Espacenet
EP 4641202 A22025-10-29113Q15223Espacenet
EP 4641203 A22025-10-2972Q15223Espacenet
JP 2025147176 A2025-10-069286Q15223Espacenet
JP 2025529142 A2025-09-042817Q15223Espacenet
JP 2025529142 A2025-09-047128Q15223Espacenet
US 12371689 B22025-07-292817Q15223Espacenet

1 to 10 of 51

See all 51 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants2,464

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleNECTIN1 papersNewest fiscal year
P30EY001792P30 Core Grant for Vision Research272025
P01CA163205Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas142025
P30CA008748Cancer Center Support Grant132025
R01EY024710A new molecular therapy against ocular herpes122025
P30DK034989Yale Liver Center92025
P30CA016672Cancer Center Support Grant82025
R01DK099097Functional outcomes of inflammatory bowel disease associated variants82025
UL1TR001863Yale Clinical and Translational Science Award72025
P30CA060553The Robert H. Lurie Comprehensive Cancer Center62025
P30DK034854Integrated Epithelial and Muscosal Biology62025

1 to 10 of 2,464Source NIH's project files

See all 2,464 nih grants

Papers3,675

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Age-stratified adverse-event reporting signals of seven ALK/ROS1 tyrosine kinase inhibitors in FAERS: a disproportionality and time to onset study.Front Pharmacol202642769117PubTator, text miningPubMed
Sphingosine 1-phosphate signalling contributes to transforming growth factor-β1-induced myofibroblast differentiation in oral cancer.PeerJ202642730290PubTator, text miningPubMed
Microbial adhesion promotes Piezo1 activation to initiate innate immunity.Nat Immunol202642717253PubTator, text miningPubMed
The TRIM-cancer paradox: BCG as a programmable vaccine platform and a mechanistic probe for rational immunotherapy design.Front Immunol202642683335PubTator, text miningPubMed
Rare missense variants in NECTIN1 alter local protein structure and may contribute to non-syndromic cleft lip with or without palate.Front Genet202642657432PubTator, text miningPubMed
Early-onset respiratory adverse event patterns of omalizumab in pediatric patients: an age-stratified FAERS pharmacovigilance study.Acta Clin Belg202642647060PubTator, text miningPubMed
Safety Comparison of Acetylcholinesterase Inhibitors Using FAERS Spontaneous-Reporting Data: Drug-Specific Reporting Signals and Time-to-Onset Dynamics.Curr Alzheimer Res202642634550PubTator, text miningPubMed
Conjugated NOD1-Centered Dual Agonists Exhibit Modest In Vitro Immunomodulation but Potent In Vivo Adjuvanticity.ACS Bio Med Chem Au202642630639PubTator, text miningPubMed
Emergence and molecular characterization of bovine alphaherpesvirus 1 subtype 1.1 in China, with in vivo characterization in a rabbit model.Microb Pathog202642628886PubTator, text miningPubMed
Intestinal Flora and Myocarditis: Potential Mechanisms and Therapeutic Strategies Affecting Disease Progression and Cardiac Function.Int J Mol Sci202642589363PubTator, text miningPubMed

1 to 10 of 3,675

See all 3,675 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/5818

GET https://conductscience.org/api/genes/v1/5818/patents?page=2